Ascendis Pharma's market cap is currently $9.25B. The company's EPS TTM is $-7.133; its P/E ratio is ―; Ascendis Pharma is scheduled to report earnings on April 2, 2025, and the estimated EPS forecast is $-1.46. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	€ 363.64M	€ 266.72M	€ 51.17M	€ 7.78M	€ 6.95M
Gross Profit	€ 319.38M	€ 222.32M	€ 39.04M	€ 4.25M	€ 6.95M
Operating Income	€ -278.76M	€ -455.54M	€ -561.81M	€ -451.79M	€ -330.62M
EBITDA	€ -290.02M	€ -411.17M	€ -556.04M	€ -423.67M	€ -328.88M
Net Income	€ -378.08M	€ -481.45M	€ -583.19M	€ -383.58M	€ -418.95M
Balance Sheet
Cash & Short-Term Investments	€ 559.54M	€ 399.44M	€ 735.46M	€ 682.06M	€ 718.79M
Total Assets	€ 1.18B	€ 825.59M	€ 1.09B	€ 1.08B	€ 979.79M
Total Debt	€ 856.62M	€ 644.26M	€ 508.38M	€ 104.96M	€ 91.97M
Net Debt	€ 297.07M	€ 252.10M	€ 63.61M	€ -341.31M	€ -492.54M
Total Liabilities	€ 1.29B	€ 971.28M	€ 826.39M	€ 201.29M	€ 141.08M
Stockholders' Equity	€ -105.71M	€ -145.70M	€ 263.35M	€ 883.63M	€ 838.71M
Cash Flow
Free Cash Flow	€ -307.62M	€ -469.80M	€ -510.19M	€ -441.88M	€ -293.10M
Operating Cash Flow	€ -306.20M	€ -467.36M	€ -495.70M	€ -417.65M	€ -271.55M
Investing Cash Flow	€ 6.88M	€ 286.47M	€ 61.73M	€ -110.58M	€ -291.20M
Financing Cash Flow	€ 443.93M	€ 134.29M	€ 396.77M	€ 351.39M	€ 602.65M

Currency in EUR

Ascendis Pharma Earnings and Revenue History

Income Statement >

Ascendis Pharma Debt to Assets

Balance Sheet >

Ascendis Pharma Cash Flow

Cash Flow >

Ascendis Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing